Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5684343 | 1.00 | ACE2 (0.39) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL9753941 | 1.00 | ACE2 (0.39) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL9120914 | 1.00 | ACE2 (0.39) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL17219696 | 1.00 | ACE2 (0.39) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL17219108 | 1.00 | ACE2 (0.39) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL497377 | 0.97 | — | — | |
| SCHEMBL497386 | 0.89 | — | — | |
| SCHEMBL4452016 | 0.86 | LMNA (0.47) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL31730270 | 0.86 | LMNA (0.47) | ACE2LMNAADH1BADH1CADH1A | |
| SCHEMBL11216030 | 0.86 | LMNA (0.47) | ACE2LMNAADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5776365-A | COMPOUNDS WITH OPTICAL ACTIVITY AND SWITCHES FOR CONTRAST | MITSUI CHEMICALS, INC. (JP) | 1998-07-07 | — | — | US | claimed |
| US-5725798-A | CARBOXYLIC ESTERS FOR ELECTRICAL APPARATUS, SWITCHES AND CONTRAST | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-10 | — | — | US | claimed |
| US-5279762-A | High speed switching | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1994-01-18 | — | — | US | claimed |
| US-5064566-A | Chirally tilted, pyrimidines, pyridines, or pyrazines, stability | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-11-12 | — | — | US | claimed |
| JP-60084388-A | — | — | None | — | — | JP | disclosed |
| US-12031079-B2 | Polymerisable LC medium and polymer film with flat optical dispersion | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| EP-4015598-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-05-22 | — | — | EP | disclosed |
| EP-3704176-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2024-05-15 | — | — | EP | disclosed |
| US-11958819-B2 | Compounds for optically active devices | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| CN-113544186-B | Organic semiconductor composition | 天光材料科技股份有限公司 | 2024-03-19 | — | — | CN | disclosed |
| EP-3794650-B1 | ORGANIC SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2024-03-13 | — | — | EP | disclosed |
| EP-3994234-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-02-21 | — | — | EP | disclosed |
| US-4740630-A | LIQUID CRYSTAL INTERMEDIATES | SEIKO EPSON CORPORATION (JP) | 1988-04-26 | — | — | US | disclosed |
| EP-0260910-A1 | 3,6-Diphenylpyridazines | Chisso Corporation (JP) | 1988-03-23 | — | — | EP | disclosed |
| EP-0260153-A2 | Cyclohexylphenylpyridazines | Chisso Corporation (JP) | 1988-03-16 | — | — | EP | disclosed |
| EP-0258340-A1 | SMECTIC LIQUID CRYSTAL PHASES | MERCK PATENT GmbH (DE) | 1988-03-09 | — | — | EP | disclosed |
| EP-0235219-A1 | BICYCLO-OCTANE DERIVATIVES | MERCK PATENT GmbH (DE) | 1987-09-09 | — | — | EP | disclosed |
| WO-1987005013-A2 | SMECTIC LIQUID CRYSTAL PHASES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1987-08-27 | — | — | WO | disclosed |
| WO-1987001113-A1 | BICYCLO-OCTANE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1987-02-26 | — | — | WO | disclosed |
| JP-S6084388-A | LIQUID CRYSTAL COMPOUND | TEIKOKU CHEM IND CORP LTD | 1985-05-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958819-B2 | Compounds for optically active devices | PDE6C, ALDH1A2, PDE6A | ACE2 1348/4885LMNA 3184/4885ADH1B 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.